--- a
+++ b/clusters/3009knumclusters/clust_34.txt
@@ -0,0 +1,487 @@
+Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of =< 1 within fourteen days of registration for protocol therapy
+Have an ECOG PS score of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS): 0, 1 or 2
+STEP I: Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 (performance status [PS] 3 allowed if secondary to pain)
+STEP II: ECOG performance status 0, 1, or 2 (PS 3 allowed if secondary to pain)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status 0-2; ECOG performance status (PS) 3 will be permitted if the decreased PS is attributed to the lymphoma
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) ? 2.
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-1 (for treatment phase)
+Has an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1.
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 to 2 for Dose Escalation phase and ECOG PS 0 to 1 for Dose Expansion phase
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+ECOG performance status (PS) score 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ? 1.
+ECOG PS 0-1.
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 to 1
+Performance status (PS) 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale
+Patients must have an ECOG Performance Status (PS) ? 1.
+Eastern Cooperative Oncology Group performance status (ECOG PS) score of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1.
+ECOG performance status (PS) ? 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Zubrod (Eastern Co-operative Oncology Group [ECOG]) Performance Status (PS) of 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (ECOG performance status [PS]) of 0, 1 or 2
+ECOG (Eastern Cooperative Oncology Group) PS (Performance Status) 0-2
+ECOG PS of 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1
+Have an ECOG performance status (PS) of ?2.
+ECOG performance status (PS) of 0 or 1 a. ECOG PS of 2 may be eligible upon the review and approval of the Medical Monitor.
+Eastern Cooperative Oncology Group performance status (PS) ?2.
+Subjects with PS of 0 or 1 on the ECOG Performance Scale
+Have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) ?2
+Subject has a performance status (PS) of 0-2 according to the Eastern Cooperative Oncology Group (ECOG) scale. Subjects with ECOG PS of 3 may be included if decreased PS is secondary to DLBCL only, and not to comorbidities.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Participant has an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+ECOG PS >= 2
+Patients must have an ECOG PS of 0-1 at screening.
+ECOG PS 0, 1, or 2.
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0, 1, or 2 (For patients enrolling in the atezolizumab arm, ECOG score must be documented within 7 days prior to first treatment.)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Performance Status (PS) ? 2:
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 to 2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Have Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 - 2
+Eastern Cooperative Oncology Group (ECOG) performance scale (PS) of 0-1; Karnofsky performance status >= 70%
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 to 2
+ECOG (Eastern Clinical Oncology Group) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2
+The patient has an ECOG PS of 0-2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ? 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+PHASE I: Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1. 4. Subjects must have adequate hematopoietic, liver, renal and coagulation function as assessed by specific laboratory criteria.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 3 or 4
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Have an ECOG PS of 0 to 1, with the exception of patients in Part 2 (Cohort 3, unfit bladder cancer patients) who may have an ECOG PS of 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Patients must have a performance status of 0 or 1 Eastern Cooperative Oncology Group (ECOG) performance status (PS) scale
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2 at registration
+Patients who have an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 2.
+Performance status: Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Has an Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or
+ECOG PS score of 0 to 2
+Performance status (PS) of 0-2 on the Eastern Cooperative Oncology Group (ECOG) scale. Note: PS 2 patients can only participate if, in the assessment of the clinical investigator, and with the consent of the medical monitor, the patient has the ability to participate in the clinical study for a minimum of at least 2 cycles.
+Have a performance status (PS) of ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+An eastern cooperative oncology group performance status (ECOG PS) of 0 to 1 at screening and adequate hematological, renal and hepatic function as defined by protocol specified criteria.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Have a performance status (PS) of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) PS.
+ECOG Performance Status (PS) 0-2;
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Have a performance status (PS) Eastern Cooperative Oncology Group (ECOG) 0-1
++ 0 for (PS=0), +2 for (PS=1), +4 for (PS >1).
+Adequate performance status (PS) as follows:\r\n* Patients >= 16 years must have Eastern Cooperative Oncology Group (ECOG) PS 0-1 and Karnofsky >= 60%\r\n* Pediatric patients < 16 years must have Lansky play-performance of 60\r\n** NOTE: Patients >= 16 years with an ECOG PS of 2 and Karnofsky >= 60 will be considered eligible at the discretion of the principal investigator if decreased ECOG performance status is felt to be related to residual neurologic deficits caused by CNS disease involvement that are not progressive or anticipated to cause clinical management problems during study participation
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 3
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1; (or Karnofsky >= 60%)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 to 1
+Eastern Cooperative Oncology Group (ECOG) performance status =< 2 for patients treated in the expansion phase; ECOG performance status (PS) =< 1 is required for participants in the dose-finding portion of the study
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) grade of 0 or 1.
+ECOG PS >2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 to 2; patients with PS 2 are being included as the primary endpoint of the study is correlation of blood based biomarkers with response; nivolumab is currently approved for both squamous and non-squamous NSCLC
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+ECOG Performance Status (PS) 0-1;
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group performance status (ECOG PS) of 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group performance status (ECOG PS) < 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of =< 2
+PRE-SCREENING: Eastern Cooperative Oncology Group performance status (ECOG PS) 0 - 1
+PRE-SCREENING: Eastern Cooperative Oncology Group performance status (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0, 1 or 2
+ECOG PS of 0 to 2 at screening.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2
+Has an Eastern Cooperative Oncology Group (ECOG) performance score (PS) score of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Patients with Eastern Cooperative Oncology Group performance scale (ECOG PS) 0 or 1
+Patients with Eastern Cooperative Oncology Group performance status (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of lesser than or equal to [<=]1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2, or 3
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group performance status (ECOG PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+ECOG performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ? 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS):\r\n* Group I: =< 2\r\n* Group II: =< 3\r\n* ECOG PS of 4 will be allowed in Group II only if symptoms due to pulmonary KS; (with Karnofsky = 20%)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2 at trial entry
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 to 2
+Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale (PS)
+Eastern Cooperative Oncology Group performance status (ECOG PS) ? 2
+Have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1. Subjects with ECOG 2 may be considered for enrollment in Parts C, D, F, and H if approved by Medical Monitor
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+ECOG performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Performance status must be Eastern Cooperative Oncology Group (ECOG) performance scale (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2; patients with a PS of 3 are eligible if the performance status is due to their malignancy, and not a co-morbid medical condition (example [ex]: perineal pain impacting their ability to sit or ambulate, etc.)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Has an ECOG PS of 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Performance score of >= 70 by Karnofsky/Lansky or performance status (PS) 0 or 1 (Eastern Cooperative Oncology Group [ECOG] =< 1)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0,1
+ECOG PS 0-2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of ? 2 (Appendix B).
+Eastern Cooperative Group (ECOG) performance status (PS) less than or equal to 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2
+Eastern Cooperative Oncology Group (ECOG) performance score (PS) of 0-2
+Patient eligible for standard induction chemotherapy based on Eastern Cooperative Oncology Group (ECOG) performance status (PS) and vital organ function at the discretion of the treating physician
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) ?2
+Has an Eastern Cooperative Oncology Group (ECOG) PS score of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+ECOG PS 0 or 1
+ECOG PS 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) grade of: 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group Performance Status 0-1 (Part A) and PS 0-2 (Part B)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Patient has a performance status (PS) of 0-2 on the Eastern Cooperative Oncology Group (ECOG) scale
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) >2.
+ECOG performance status (PS) ? 1
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1.
+Subject has an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1
+ECOG PS 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Performance status (ECOG PS) 0-2
+PS ECOG < 2
+ECOG performance status (PS) 0 to 2.
+ECOG Performance Status (PS) 0-1;
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+RENAL & BLADDER: Eastern Cooperative Oncology Group (ECOG) performance status (PS) grade of ? 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Patient has an Eastern Cooperative Oncology Group performance status (ECOG PS) =< 1 that the investigator believes is stable at the time of screening.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Patient has an Eastern Cooperative Oncology Group Performance Status (ECOG PS) =< 1 that the investigator believes is stable at the time of screening
+Patient has Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+ECOG performance status (PS) 0-3 (restricted to ECOG PS 0-2 if >= 70 years of age)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+ARM A: Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+ARM B: ECOG performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group performance status (ECOG PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2 or 3
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) unless due to neurologic deficits caused by CNS lymphoma with the following exceptions: patients with ECOG performance status (PS) = 4 where neurologic deficits are unlikely to resolve with tumor resolution and may cause clinical management problems are excluded
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of < 2
+Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1\r\n* Patients with ECOG PS of 2, secondary to the underlying disease, may be enrolled
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0,1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Performance status (PS) 0, 1, or 2 per the Eastern Cooperative Oncology Group (ECOG) performance status scale (Karnofsky performance score >= 50%)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Subjects must have ECOG PS of 0 to 2.
+Eastern Cooperative Oncology Group (ECOG) performance score (PS) <2.
+ECOG PS 0-1
+performance status (PS) of 0 to 1 on the Eastern Cooperative Oncology Group scale
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 1 at trial entry
+Patient must have ECOG PS of 0 to 2
+ECOG PS 0 - 2
+The patient has an ECOG performance score (PS) of 0-2.
+The patient has an ECOG performance score (PS) of 0-2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1 (see Appendix 21.2).
+ECOG PS ?2 (Eastern Cooperative Oncology Group [ECOG] criteria)
+Subject has an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1;
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ? 2.
+Patients with Gynecologic Oncology Group (GOG) performance status of 0 or 1 OR Eastern Cooperative Oncology Group (ECOG) PS of 0 or 1 OR Karnofsky performance status (PS) >= 80%
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) grade of 0 or 1
+ECOG performance status (PS) of 0 or 1
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) at 0, 1, 2; (i.e. the patient must be able to care for himself/herself with only occasional help from others)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ? 2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern cooperative oncology group performance status (ECOG PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+ECOG Performance Status (PS) score of 0-1.
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 to 2
+Eastern Cooperative Oncology Group performance status (ECOG PS) 0, 1 or 2.
+Have a performance status (PS) of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale.
+Eastern cooperative oncology group performance status (ECOG PS) of 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Arm (ECOG) performance status (PS)
+PS 0 to 1
+PS 2
+Eastern Cooperative Oncology Group (ECOG) PS 0-1
+ECOG-PS 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+ECOG PS of ?1.
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Have Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1 at the time of enrollment.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2 or 3
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group performance status (ECOG PS) score of 0-1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) (ECOG PS) ? 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+ECOG PS of 0 or 1. Patients with an ECOG PS of 2 may be entered upon review and approval of the medical monitor.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+ECOG PS of 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS): 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ? 1; PS=2 patients may be considered
+Subjects must have ECOG PS of 0 to 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Has an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ? 1
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 to 2.
+Eastern Cooperative Oncology Group performance status (ECOG PS) 0 to 2. In case of ECOG PS 2, the PS has to be due to metastatic prostate cancer to the bone.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) Score 0 - 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Subjects must have Eastern Cooperative Oncology Group (ECOG) Performance status (PS) of 0 to 2.
+Patients who have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 1
+Eastern Cooperative Oncology Group (ECOG)-Performance Status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Zubrod performance status (PS) 0-2 or equivalent Karnofsky PS
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+ECOG Performance Status (PS) </= 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+ECOG performance status (PS) 0-2;
+ECOG PS 0-2
+Performance score of >= 70 by Karnofsky/Lansky or performance status (PS) 0 to 1 (Eastern Cooperative Oncology Group [ECOG] =< 1)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) ?3
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-1.
+ECOG PS ? 1;
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1
+ECOG Performance Status (PS) of 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1.
+ECOG PS 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 2
+ECOG PS: 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0-1 at enrollment
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 2
+Karnofsky performance score of >= 70 is required or Eastern Cooperative Oncology Group (ECOG) score, performance status (PS) = 0-2
+ECOG PS of 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eligible study subjects must have Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+ECOG [Eastern Cooperative Oncology Group] Performance Status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0,1 or 2
+Patient has an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+ECOG PS ? 2
+Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1
+Patient has an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+PS 0 or 1 on the ECOG scale
+Eastern Co-Operative Group (ECOG) Performance Status (PS) Score 0 - 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, 2
+Eastern Cooperative Oncology Group Performance Scale (ECOG-PS) ?2
+Eastern Cooperative Oncology Group performance status( PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+ECOG PS (Eastern Cooperative Group Performance Status) of 0 or 1. 8. Ability to swallow oral capsules without difficulty. 9. Pregnancy Prevention Risk Management Plan:
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1 and/or Karnofsky PS of >= 70%
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1 and estimated life expectancy ? 3 months.
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of ? 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ? 2
+Subjects with an ECOG PS other than 2
+Subjects must have ECOG PS of 0 to 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-3
+Eastern Cooperative Oncology Group performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1 (inclusive)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) > 2
+ECOG PS 0-2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG)performance status (PS) ? 1
+Patients with an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+ECOG PS 0 or 1
+Eastern Cooperative Oncology Group (ECOG) PS = 2
+ECOG PS 0 to 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+The patient has an Eastern Cooperative Oncology Group (ECOG) performance score (PS) of 0-2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern cooperative oncology group (ECOG) performance status (PS) 0-1;
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1
+The participant has an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1.
+ECOG PS 0-2
+ECOG PS 0-2
+ECOG PS 0-2
+ECOG PS 0-2
+The participant has an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) grade of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Eastern Cooperative Oncology Group performance status (ECOG PS) < 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 or 3
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 1
+Eastern Cooperative Oncology Group (ECOG) Performance status (PS) ? 2.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) =< 3
+Performance scale (PS) 0-3
+Eastern Cooperative Oncology Group performance status (ECOG PS) of =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0, 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+Eastern Cooperative Oncology Group performance status (PS) of 0 – 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
+Minocycline trial only: patients with Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0-2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-3
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+ECOG Performance Status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+For patient aged ? 10 years: Eastern Cooperative Oncology Group Performance Status (ECOG PS) ? 2.
+Eastern Cooperative Oncology Group Performance Scale (ECOG PS) of 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 to 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1.
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 (restricted to ECOG performance status [PS] 0-2 if age > 70 years)
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 (restricted to ECOG performance status [PS] 0-2 if age > 70 years)
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 (restricted to ECOG performance status [PS] 0-2 if age > 70 years)
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-1
+Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 (restricted to ECOG performance status [PS] 0-2 if age > 70 years).
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1 or 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
+Eastern Cooperative Oncology Group performance status (ECOG PS) =< 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) > 2
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1
+Criteria 6, Eastern Cooperative Oncology Group performance status (ECOG PS) 0 or 1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) of ? 1 (see APPENDIX 1).
+Eastern Co-Operative Group (ECOG) Performance Status (PS) of 0-1
+Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-3
+Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0 or 1.
+Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 2.
+Have a performance status (PS) ?1 on the Eastern Cooperative Oncology Group (ECOG) scale.
+Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0 to 2. (see Appendix A)